Monograph Details
|
|
Dermatological Disorders
> Miscellaneous dermatological conditions
|
|
PROPECIA |
| Manufacturer |
|
Merck & Co., Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Type II 5α-reductase specific inhibitor. |
| Generic Name |
|
Finasteride 1mg; tabs. |
| Indications |
|
Treatment of male pattern hair loss (androgenetic alopecia) in men only. |
| Children |
|
<18yrs: not recommended. |
| Adults |
|
1mg once daily. |
| Contraindications |
|
Women. Children. Women of childbearing potential must not handle crushed or broken tablets. Pregnancy (Cat.X). Nursing mothers. |
| Precautions |
|
Hepatic dysfunction. Consider doubling PSA in men >41 yrs of age without BPH who are undergoing PSA test. |
| Adverse Reactions |
|
Decreased libido, erectile dysfunction, ejaculation disorder (all rare). |
| How Supplied |
Tabs—30
ProPak—(3 x 30), (1 x 90) tabs |
|
|
|
|
